Niemiec-Górska, A.; Labus, Ł.; Mielcarska, S.; Glück, J.; Czuba, Z.; Cyrnek, M.; Branicka, O.; Rymarczyk, B.; Gawlik, R.
Analysis of Selected Serum Cytokines to Evaluate the Early Efficacy of Benralizumab, Dupilumab, and Mepolizumab in Severe Eosinophilic Asthma Treatment. Int. J. Mol. Sci. 2025, 26, 10075.
https://doi.org/10.3390/ijms262010075
AMA Style
Niemiec-Górska A, Labus Ł, Mielcarska S, Glück J, Czuba Z, Cyrnek M, Branicka O, Rymarczyk B, Gawlik R.
Analysis of Selected Serum Cytokines to Evaluate the Early Efficacy of Benralizumab, Dupilumab, and Mepolizumab in Severe Eosinophilic Asthma Treatment. International Journal of Molecular Sciences. 2025; 26(20):10075.
https://doi.org/10.3390/ijms262010075
Chicago/Turabian Style
Niemiec-Górska, Aleksandra, Łukasz Labus, Sylwia Mielcarska, Joanna Glück, Zenon Czuba, Marcin Cyrnek, Olga Branicka, Barbara Rymarczyk, and Radosław Gawlik.
2025. "Analysis of Selected Serum Cytokines to Evaluate the Early Efficacy of Benralizumab, Dupilumab, and Mepolizumab in Severe Eosinophilic Asthma Treatment" International Journal of Molecular Sciences 26, no. 20: 10075.
https://doi.org/10.3390/ijms262010075
APA Style
Niemiec-Górska, A., Labus, Ł., Mielcarska, S., Glück, J., Czuba, Z., Cyrnek, M., Branicka, O., Rymarczyk, B., & Gawlik, R.
(2025). Analysis of Selected Serum Cytokines to Evaluate the Early Efficacy of Benralizumab, Dupilumab, and Mepolizumab in Severe Eosinophilic Asthma Treatment. International Journal of Molecular Sciences, 26(20), 10075.
https://doi.org/10.3390/ijms262010075